Embed Size (px)
Citation preview
BBOOAARRDD OOFF DDIIRREECCTTOORRSS
AAUUGGUUSSTT 22001166
Executive Responsible John Grinnell, Deputy Chief Executive and Chief Finance Officer
Paper prepared by (if different from above)
Executive Directors
Category of Item Strategic Direction and Development
Performance and Governance
Context Previous Board discussion
Link to National Policy
Link to Trust’s Strategic Objectives
Risk if no action taken
Executive Summary
The Trust’s Month 4 Performance Report is detailed in the attached paper.
Received or approved by
Legal Implications None
Recommendation It is recommended that the Board note:
The performance during July 2016 (Month 4).
Acronyms and Abbreviations
VTE – Venous Thromboembolism DVT – Deep Vein Thrombosis PE – Pulmonary Embolism CQUIN – Commissioning for Quality and Innovation Payment Programme RTT – Referral to Treatment UCL – Upper Confidence Limit LCL – Lower Confidence Limit BADS - British Association of Daycase Surgery I&E - Income and Expenditure C. difficile – Clostridium difficile (bacterial infection) MRSA – Methicillin-resistant Staphylococcus aureus (bacterial infection) STF – Sustainability and Transformational Plan
Subject/Title July (Month 4) Integrated Performance Report
Nature of Report For Information
For Discussion
For Approval
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 1
BOARD OF DIRECTORS
INTEGRATED PERFORMANCE REPORT
JULY 2016
1. Introduction 1.1 The integrated performance report has been developed in order to assist the Board
in monitoring the delivery of key performance metrics against local and national targets.
1.2 The report covers the five key domains of: - Patient Safety, Patient Experience, Resources, Efficiency and External Perception.
1.3 Performance measurement targets within these domains are based on the following
The core standards set nationally by Monitor, NHS England, Welsh Assembly Government and the Care Quality Commission
Any locally agreed Commissioner driven targets including CQUIN quality improvement
Internal performance targets in line with the Trust’s Annual Operating Plan objectives.
1.4 The scorecard format provides an overview of the performance within each domain
with further detail of specific metrics in graphical and tabular format.
1.5 The scorecard utilises two graphical presentation methods; line graphs and statistical process control (SPC) charts. SPC charts enable the analysis of the variability of a metric relative to average performance. Data points within the upper and lower limits are linked to natural variation in performance levels.
1.6 As agreed, a review of the scorecard is underway which will result in a revised format from Quarter 2 of 2016-17.
2. Overview 2.1 Month 4 saw the Trust maintain its excellent patient experience performance. Whilst
overall the safety domain performed well, we report a spinal wrong level surgery never event in the report.
2.2 Our RTT performance met trajectory however a growth in referrals and the impact of lower activity than planned during the summer holiday period is putting increasing pressure in delivering our plan. Theatre activity levels in July were lower than anticipated and have had an adverse impact on our finances. With similar challenges forecast in August, an executive led group to oversee performance has been initiated.
3. Performance Overview 3.1 Domain 1 – Patient Safety
3.1.1 Overview – Seven of the ten key metrics were rated as green in month. Although
the number of incidents remains low overall, the Trust continually scopes areas for improvement and ensures learning is communicated throughout all appropriate areas. The following exceptions are noted for month 4.
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 2
3.1.2 Serious Incidents – The scorecard reports one serious incident in July where a patient on the care of the elderly ward fell and sustained a fracture. The incident has been reported to the relevant external bodies. A further incident occurred in July that has also been reported as a Never Event with STEIS in August, therefore will show on the August scorecard. A patient underwent spinal surgery and during post-procedure checks a CT scan showed that wrong level spinal surgery had been performed. The Consultant spoke to the patient and their family to explain the outcome and the correct level surgery was consented and carried out the following day.
3.1.3 Mortality Rates – There were no patient deaths in July.
3.1.4 Hospital Acquired VTE (DVT or PE) – A patient was diagnosed with hospital acquired deep vein thrombosis six days following a total knee replacement. The patient had been risk assessed on admission and following diagnosis of the DVT, the patient’s care plan was updated on the ward. One incident remains within the monthly tolerance levels.
3.1.5 Patients Falls (Harms) – Seventeen patient falls occurred in July with eight patients capable of receiving medical advice not complying with the medical advice given at the time of the incident. For Inpatients, there were sixteen falls that when compared to activity levels correlates to 2.50% of activity. There was one further fall in Outpatients. Five patients experienced low level harm of skin abrasion (2), loss of consciousness (1) and pain (2). One further patient experienced moderate pain. Although six incidents with harm is above the limit of two, it remains within normal variation levels.
3.1.6 Hospital Acquired Pressure Ulcers – Pressure Ulcers are graded on a scale from 1 to 4, with grade 1 relating to minimal harm and grade 4 being full skin loss and the highest level of harm.
There were no incidents to report in July.
3.1.7 Medication Errors (Harms) – The graph for this KPI within the scorecard displays the overall errors per month and those with harm. The performance rating is based on any harms. Twelve medication incidents relating to patient care at the hospital were recorded during July which were categorised as Prescribing (2), Administration (2), Dispensing (7) and the incorrect advice given to a patient (1). No patients experienced harm as a result of these errors.
3.1.8 28 day Readmission Rates to RJAH – Seven patients were readmitted as an emergency within 28 days of initial discharge in June 2016 giving a readmission rate of 1.15% against the 1% limit. The reasons for readmission were wound issues (4), pain (1), query possible infection (1) and revision lumbar discectomy (1).
3.2 Domain 2 - Patient Experience
3.2.1 Overview – July was a positive month for patient feedback with three hundred and fifty five compliments received, the highest so far this year. The comments received frequently refer to the friendly and professional manner that staff demonstrate throughout all areas of the patient’s pathway of care. The following exceptions are noted for month 4.
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 3
3.2.2 NHS Friends & Family Test – The Friends and Family metrics within the scorecard is a combined measure representing the percentage of both inpatients and outpatients that would and would not recommend the Trust. In line with the national metrics, passive responses are not included within calculations. The results for July indicate that 99.13% of patients would recommend the Trust. 0.70% stated they would not recommend the Trust. Those who were unlikely to recommend were from a cross-section of areas and left no specific comments. The latest national averages published for May 2016 indicate that 96% of inpatients recommend Trusts with 1% not recommending so our performance continues to exceed those levels.
3.2.3 Complaints – Two complaints were received in July, below the tolerance level. One
of the complaints related to clinical care with reasons associated with the outcome of care. A further operational complaint related to appointment allocation following multiple DNAs. Each complaint is currently under review in line with the Trust’s Complaints Policy.
3.2.4 Delayed Discharges – The delayed discharges rate is reported as the total number
of delayed days against the total available bed days for the month. In July there were 250 delayed bed days. When compared to the available beds this gives a rate of 5.04% which is higher (being worse) than the 2.50% target. As with previous months, the delays are predominately Spinal Injuries patients who were awaiting care packages. As a Trust we are unable to directly control this so we continue to raise the issue with the relevant Commissioners.
3.2.5 Access to Bone Tumour Services – All cancer targets were achieved in July. Since last month’s scorecard a shared breach has been uploaded to the national cancer waits database against the 62 day standard so performance has been updated to 66.67% for June. The patient commenced a pathway at this Trust and was then referred to SaTH on day 32 of their pathway, however, SaTH did not commence their definitive treatment within target. We are currently challenging the breach share allocation, as the patient was transferred to SaTH in a timely manner.
3.2.6 Access to Services - English – Our July performance is 88.75% against the 92% open pathway performance for patients waiting 18 weeks or less to start their treatment. This is against a trajectory plan of 88.29%. The total number of breaches has increased by 63 from 687 to 750. It is important to note that overall list size has increased during the first quarter; we have seen an increase in the number of referrals received and have notified the Commissioners of the position.
3.2.7 Patients waiting over 52 weeks – At the end of July there were no hospital initiated 52 week waits for English patients. There were 10 English patients (10 patient choice) and 10 Welsh patients waiting over 52 weeks (10 BCU). All patients waiting over 40 weeks are being monitored on a weekly basis, with Clinical Commissioning Groups. Welsh long wait patients are being managed in line with revised contract instructions and we are currently in discussions regarding the reduction profile for 2016/17. Our ability to meet our demand for spinal disorder patients remains a key area of focus operationally.
3.3 Domain 3 – Efficiency Overview – July was a challenging month in terms of patient efficiency with a number of metrics rated as amber in month. Activity figures were lower than plan in July.
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 4
Internal theatre throughput levels fell below plan with 91.24% of theatre lists being utilised compared to a target of 96.60%. However, cases per session improved and exceeded target at 2.25. The following exceptions are noted for month 4:
3.3.1 Daycase Performance – July saw an improvement in the performance against the composite target for BADS with performance reported at 85.96% against the 84% target and is rated green in month. The July casemix was a contributory factor in this although a daycase working group does meet on a monthly basis where performance against this standard is monitored. The Daycase rate for July deteriorated to 46.42% against the 51% target so is rated amber in month. The new development will support improvement in this area with extended opening hours for the unit supported by additional therapy service provision.
3.3.2 Admission on Day of Surgery – The proportion of patients admitted on the day of surgery came back to the levels seen earlier in the year at 95.67%. The frequency of the forward look process is being reviewed to ensure there is continued focus on this measure.
3.3.3 Average Length of Stay – Although the average length of stay was maintained at 3.85 days, the metric is rated as amber due to the target step change. Sustained focus is required to ensure this reduces over the remainder of the year. Despite a dip, the proportion of Primary Hip and Knee patients discharged in three days or less continues to exceed its target at 64.02% in July.
3.3.4 Outpatient Productivity – The DNA rate decreased in July improving to 5.69% compared to 6.54% the previous month; however the target of 5.4% was not quite achieved. Areas of concern were added to the text reminder service and regular reviews will continue to make effective use of this system.
3.4 Domain 4 – Resources 3.4.1 Overview – We continue to adjust our Income and Expenditure performance to
reflect the criteria attached to the control total target set by NHS Improvement. This excludes performance driven by donated assets (depreciation and income) and sustainability and transformation funding (STF). Achievement of our control total target at each quarterly milestone is a key deliverable in being eligible to receive the £0.5m of Sustainability and Transformation funding included in our plan. We have received £125k of this to date based on our quarter 1 performance. Our adjusted surplus for July was £41k against a plan of £191k leaving us £150k adrift of target. The shortfall was driven by lower than planned levels of inpatient activity and income as a result of higher than anticipated consultant annual leave.
On a cumulative basis we have achieved a control total adjusted surplus of £341k (£507k including STF) which is £135k behind plan.
A further shortfall of activity and clinical income is expected for August. An executive led finance and RTT task and finish group has been set up to ensure appropriate booking of patients that optimises performance of both our key targets and to oversee a recovery of lost activity.
Our FSRR for July has remained at a 4 (lowest level of risk). Our EBITDA margin year to date is 4.9% which is lower than plan by 0.6%.
The key features of the financial performance for month 4 are detailed below:
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 5
3.4.2 Income - Clinical income fell short of plan by £263k driven by:
Reduced theatre activity delivered internally £259k
Reduced levels of outsourcing to the independent sector and pass through drugs £154k (benefiting cost base)
Partly offset by:
Increased non surgical activity and outpatients £150k
Private patient income fell short of plan by £137k which was largely casemix driven.
3.4.3 Expenditure – Overall pay costs were £107k under plan in month driven by lower than planned levels of ‘out of job plan’ working. Agency spend remains a key area of focus for our regulator. In month our agency spend was £134k which was within our control limit. The number of agency agreements exceeding national price caps reduced by 2 to 13 and these continue to be reported to NHSI on a weekly basis. Non pay costs overall were £160k under plan linked to pass through items as reflected in the cost base.
3.4.4 Cost Improvements – Our efficiency plan has been set at £3.5m for the year and
full delivery of this is one of the core components of our ability to hit our control total. In month £201k was recognised against a plan of £266k whilst year to date we have achieved £698k against a plan of £759k leaving us £61k behind plan. The underperformance is largely linked to one of our key schemes (valued at £300k) associated with increased productivity in our theatres. As we have not met our planned internal activity levels this scheme has fallen behind plan. Delivery of remaining schemes is being closely monitored through our performance management framework and further mitigating schemes are currently being worked up and overseen by the task and finish group.
3.4.5 Capital Expenditure amounted to £0.83m in month and primarily related to the
construction of the new Theatres and Tumour unit. Year to date we have spent £2.9m which is £360k ahead of plan largely driven by an earlier than anticipated commencement of the equipment replacement programme. We anticipate staying within our overall capital plan of £5m.
3.4.6 Cash Balances reduced by £0.3m in month to £4.6m which is £0.2m behind planned
levels linked to the profile of the capital programme.
3.4.7 Sickness Absence – Sickness absence for July decreased to 3.33%, following a
reduction in short terms absences, stress and anxiety. The following exception report stating areas below the target is included for information. Medicine 4.11% Theatre 3.69% Surgery 3.35% -
3.4.8 Staff Stability Index – The stability index for July improved to 91.05% which is just above (better than) the 91% target. The following exception report stating areas below the target is included for information. Corporate 88% - Theatre 90% Medicine 90%
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 6
3.4.9 Staff Appraisal – Following further focus on this area, staff appraisals in July increased to 93.30% Trust wide of staffing having undertaken an appraisal within the past 12 months, above the 90% target.
3.4.10 Staffing Establishment – The Trust monitor staffing levels twice daily and this is reported to NHS England monthly. As part of a review of our reporting of this indicator for this financial year we have changed the planned fill rate to be measured against a fixed establishment based on safer staffing levels and will provide a narrative on where we may vary from this in a planned way for example if we reduce bed numbers or for lower patient complexity. Previously the plan has been flexed to take account of these issues however it is felt to be clearer to fix the planned levels and narrate any variance.
3.4.11 All escalation processes have been followed to ensure patient safety is maintained with the shift fill rate of 97.8% above the target of 90%. The monthly Unify table is shown below.
The average fill rates fell below target in some areas throughout the month but Wards remained safely staffed and supporting data monitors the patient numbers on the Wards at these times and includes the monitoring of patient acuity levels.
3.5 Domain 5 – External Perception
3.5.1 As referenced in the resources section our financial performance and sustainability risk rating remained at a level 4 (lowest level of risk).
3.5.2 NHS Improvements’ governance rating shows the Trust being in breach of its licence
and is therefore rated as red on the scorecard.
4. Recommendation 4.1 It is recommended that the Board:
Note the performance for July (Month 4)
John Grinnell Deputy Chief Executive and Chief Finance Officer
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 7
Balanced Scorecard - Trust
July 2016 - Month 4
Month Key Metric Actual YTD Change Forecast Month Key Metric Actual YTD Change Forecast
Jul-16 Infection Control g g same g Jul-16 Friends & Family Test g g same gJul-16 Serious Incidents a a same a Jul-16 Number of Complaints g g same gJul-16 Never Events g g same g Jul-16 Theatre Cancellations g a same gJul-16 Unexpected Deaths g g same g Jul-16 Delayed Discharges r r same aJul-16 Clinical Quality a a worse g Jul-16 Access to Bone Tumour Services g g same gJul-16 Safety Thermometer g a same g Jul-16 Access to Services - English r r worse gJul-16 Medication Errors and those with Harm g g same g Jul-16 Patients Waiting Over 52 Weeks r r same gJul-16 Pressure Ulcer Assessments g g same gJul-16 28 Day Emergency Readmission Rate a a worse gJul-16 VTE Assessments Undertaken g g same g
↑
← →
↓
Month Key Metric Actual YTD Change Forecast Month Key Metric Actual YTD Change Forecast
Jul-16 Sickness Absence a a same g Jul-16 Demand for Services a a same aJul-16 Staff Stability Index g a better g Jul-16 Activity - Surgery a g worse gJul-16 Staff Appraisal g a better g Jul-16 Activity - Medicine a g worse gJul-16 Safe Staffing - % Shift Fill Rate g g same g Jul-16 Daycase Performance g a better gJul-16 Net Surplus r r worse a Jul-16 Admission on Day of Surgery g g better gJul-16 CIP Delivery a a worse a Jul-16 Theatre Efficiency a a worse aJul-16 Capital Expenditure a a worse g Jul-16 Average Length of Stay g g same gJul-16 PSPP g g same g Jul-16 Bed Utilisation r a worse aJul-16 Cash Balance g g same g Jul-16 Outpatient Productivity a a better a
Jul-16 New to Follow Up Ratio (Consultant Led Activity) g g same g
Resources EfficiencyOverall Performance Overall Performance
Patient Safety Patient ExperienceOverall Performance Overall Performance
VISION
To be the leading centre for high quality, sustainable Orthopaedic and related care, achieving excellence in both experience and outcomes for our
patients
Month Key Metric Actual YTD Change Forecast
Jul-16 Monitor Risk Rating - Finance g g same a
Jul-16 Monitor Risk Rating - Organisational Health r r same r
Overall PerformanceExternal Perception
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 8
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Safety
Infection Control
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Hospital Acquired MRSA Bacteraemia
0.00
1.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Infection Control
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Hospital Acquired C.Difficile
0.00
1.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 2.00 a
Jul-16 0.00 1.00 a
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Serious Incidents
0.00
1.00
2.00
3.00
4.00
5.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Never Events
0.00
1.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 9
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Safety
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Never Events
0.00
1.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 0.00 g
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Unexpected Deaths
0.00
1.00
2.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Clinical Quality
Period Target Actual PerformanceApr-16 3.00 0.00 gMay-16 3.00 0.00 gJun-16 3.00 4.00 aJul-16 3.00 1.00 g
Aug-16 3.00Sep-16 3.00Oct-16 3.00Nov-16 3.00Dec-16 3.00Jan-17 3.00Feb-17 3.00Mar-17 3.00
Hospital Acquired VTE (DVT or PE)
0.00
1.00
2.00
3.00
4.00
5.00
6.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
Patient Safety
Clinical Quality
Period Target Actual PerformanceApr-16 2.00 5.00 aMay-16 2.00 2.00 gJun-16 2.00 1.00 gJul-16 2.00 6.00 r
Aug-16 2.00Sep-16 2.00Oct-16 2.00Nov-16 2.00Dec-16 2.00Jan-17 2.00Feb-17 2.00Mar-17 2.00
Total Patient Falls and those with Harm
0.00
0.50
1.00
1.50
2.00
2.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
16.00
17.00
18.00
19.00
20.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Harms Total
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 10
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Safety
Clinical Quality
Period Target Actual PerformanceApr-16 2.00 5.00 aMay-16 2.00 2.00 gJun-16 2.00 1.00 gJul-16 2.00 6.00 r
Aug-16 2.00Sep-16 2.00Oct-16 2.00Nov-16 2.00Dec-16 2.00Jan-17 2.00Feb-17 2.00Mar-17 2.00
Total Patient Falls and those with Harm
0.00
0.50
1.00
1.50
2.00
2.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
16.00
17.00
18.00
19.00
20.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Harms Total
Patient Safety
Clinical Quality
Period Target Actual Performance
Apr-16 1.00 0.00 g
May-16 1.00 0.00 g
Jun-16 1.00 0.00 g
Jul-16 1.00 0.00 g
Aug-16 1.00Sep-16 1.00Oct-16 1.00Nov-16 1.00Dec-16 1.00Jan-17 1.00Feb-17 1.00
Mar-17 1.00
Hospital Acquired Pressure Ulcers - Grade 2
0.00
1.00
2.00
3.00
4.00
5.00
6.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Clinical Quality
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 1.00 r
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Hospital Acquired Pressure Ulcers - Grades 3 or 4
0.00
1.00
2.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Safety
Safety Thermometer
Period Target Actual PerformanceApr-16 95.00 99.17 gMay-16 95.00 97.73 gJun-16 95.00 98.78 gJul-16 95.00 98.19 g
Aug-16 95.00Sep-16 95.00Oct-16 95.00Nov-16 95.00Dec-16 95.00Jan-17 95.00Feb-17 95.00Mar-17 95.00
Safety Thermometer - % with no new harms
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
101.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 11
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Safety
Safety Thermometer
Period Target Actual PerformanceApr-16 95.00 99.17 gMay-16 95.00 97.73 gJun-16 95.00 98.78 gJul-16 95.00 98.19 g
Aug-16 95.00Sep-16 95.00Oct-16 95.00Nov-16 95.00Dec-16 95.00Jan-17 95.00Feb-17 95.00Mar-17 95.00
Safety Thermometer - % with no new harms
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
101.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
Patient Safety
Safety Thermometer
Period Target Actual PerformanceApr-16 95.00 92.56 rMay-16 95.00 92.42 rJun-16 95.00 95.73 gJul-16 95.00 96.99 g
Aug-16 95.00Sep-16 95.00Oct-16 95.00Nov-16 95.00Dec-16 95.00Jan-17 95.00Feb-17 95.00Mar-17 95.00
Safety Thermometer - % of patients with harm free care
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
84.00
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
Patient Safety
Period Target Actual PerformanceApr-16 2.00 1.00 gMay-16 2.00 3.00 aJun-16 2.00 0.00 gJul-16 2.00 0.00 g
Aug-16 2.00Sep-16 2.00Oct-16 2.00Nov-16 2.00Dec-16 2.00Jan-17 2.00Feb-17 2.00Mar-17 2.00
Medication Errors and those with Harm
0.00
0.50
1.00
1.50
2.00
2.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
11.00
12.00
13.00
14.00
15.00
16.00
17.00
18.00
19.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Harms Total
Patient Safety
Period Target Actual PerformanceApr-16 99.00 100.00 g
May-16 99.00 99.90 g
Jun-16 99.00 100.00 g
Jul-16 99.00 100.00 g
Aug-16 99.00Sep-16 99.00Oct-16 99.00Nov-16 99.00Dec-16 99.00Jan-17 99.00Feb-17 99.00
Mar-17 99.00
Pressure Ulcer Assessments
98.40
98.60
98.80
99.00
99.20
99.40
99.60
99.80
100.00
100.20
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 12
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Safety
Period Target Actual PerformanceApr-16 99.00 100.00 g
May-16 99.00 99.90 g
Jun-16 99.00 100.00 g
Jul-16 99.00 100.00 g
Aug-16 99.00Sep-16 99.00Oct-16 99.00Nov-16 99.00Dec-16 99.00Jan-17 99.00Feb-17 99.00
Mar-17 99.00
Pressure Ulcer Assessments
98.40
98.60
98.80
99.00
99.20
99.40
99.60
99.80
100.00
100.20
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Safety
28 Day Emergency Readmission Rate
Period Target Actual PerformanceApr-16 1.00 1.36 rMay-16 1.00 0.97 gJun-16 1.00 1.15 aJul-16 1.00 No Data g
Aug-16 1.00Sep-16 1.00Oct-16 1.00Nov-16 1.00Dec-16 1.00Jan-17 1.00Feb-17 1.00Mar-17 1.00
28 Days Emergency Readmissions to RJAH Following an
Overnight Stay
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
Patient Safety
Period Target Actual PerformanceApr-16 95.00 100.00 g
May-16 95.00 99.91 g
Jun-16 95.00 100.00 g
Jul-16 95.00 99.91 g
Aug-16 95.00Sep-16 95.00Oct-16 95.00Nov-16 95.00Dec-16 95.00Jan-17 95.00Feb-17 95.00
Mar-17 95.00
VTE Assessments Undertaken
84.00
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 13
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Experience
Friends & Family Test
Period Target Actual PerformanceApr-16 90.00 98.71 g
May-16 90.00 98.76 g
Jun-16 90.00 98.72 g
Jul-16 90.00 99.13 g
Aug-16 90.00Sep-16 90.00Oct-16 90.00Nov-16 90.00Dec-16 90.00Jan-17 90.00Feb-17 90.00
Mar-17 90.00
Friends & Family - % Would Recommend (Inpatients and
Outpatients)
84.00
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Friends & Family Test
Period Target Actual PerformanceApr-16 0.00 0.16 a
May-16 0.00 1.06 a
Jun-16 0.00 0.92 a
Jul-16 0.00 0.70 a
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Friends & Family - % Would Not Recommend (Inpatients
and Outpatients)
0.00
0.20
0.40
0.60
0.80
1.00
1.20
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Period Target Actual PerformanceApr-16 9.00 10.00 aMay-16 9.00 9.00 gJun-16 9.00 7.00 gJul-16 9.00 2.00 g
Aug-16 9.00Sep-16 9.00Oct-16 9.00Nov-16 9.00Dec-16 9.00Jan-17 9.00Feb-17 9.00Mar-17 9.00
Number of Complaints
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Mean UCL LCL Actual
Patient Experience
Theatre Cancellations
Period Target Actual Performance
Apr-16 0.70 0.26 g
May-16 0.70 0.27 g
Jun-16 0.70 0.51 g
Jul-16 0.70 0.66 g
Aug-16 0.70Sep-16 0.70Oct-16 0.70Nov-16 0.70Dec-16 0.70Jan-17 0.70Feb-17 0.70
Mar-17 0.70
% Reportable Cancellations
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 14
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Experience
Theatre Cancellations
Period Target Actual Performance
Apr-16 0.70 0.26 g
May-16 0.70 0.27 g
Jun-16 0.70 0.51 g
Jul-16 0.70 0.66 g
Aug-16 0.70Sep-16 0.70Oct-16 0.70Nov-16 0.70Dec-16 0.70Jan-17 0.70Feb-17 0.70
Mar-17 0.70
% Reportable Cancellations
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Theatre Cancellations
Period Target Actual Performance
Apr-16 0.00 0.00 g
May-16 0.00 1.00 r
Jun-16 0.00 0.00 g
Jul-16 0.00 0.00 g
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Cancellations Not Rebooked within 28 Days
0.00
0.50
1.00
1.50
2.00
2.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Experience
Delayed Discharges
Period Target Actual PerformanceApr-16 2.50 7.04 rMay-16 2.50 6.25 rJun-16 2.50 5.63 rJul-16 2.50 5.04 r
Aug-16 2.50Sep-16 2.50Oct-16 2.50Nov-16 2.50Dec-16 2.50Jan-17 2.50Feb-17 2.50Mar-17 2.50
% Delayed Discharges Rate
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 93.00 100.00 g
May-16 93.00 95.24 g
Jun-16 93.00 100.00 g
Jul-16 93.00 93.94 g
Aug-16 93.00Sep-16 93.00Oct-16 93.00Nov-16 93.00Dec-16 93.00Jan-17 93.00Feb-17 93.00
Mar-17 93.00
Cancer Two Week Wait
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 15
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 93.00 100.00 g
May-16 93.00 95.24 g
Jun-16 93.00 100.00 g
Jul-16 93.00 93.94 g
Aug-16 93.00Sep-16 93.00Oct-16 93.00Nov-16 93.00Dec-16 93.00Jan-17 93.00Feb-17 93.00
Mar-17 93.00
Cancer Two Week Wait
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 96.00 100.00 g
May-16 96.00 100.00 g
Jun-16 96.00 100.00 g
Jul-16 96.00 100.00 g
Aug-16 96.00Sep-16 96.00Oct-16 96.00Nov-16 96.00Dec-16 96.00Jan-17 96.00Feb-17 96.00
Mar-17 96.00
31 Days First Treatment (Tumour)
94.00
95.00
96.00
97.00
98.00
99.00
100.00
101.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 94.00 100.00 g
May-16 94.00 100.00 g
Jun-16 94.00 100.00 g
Jul-16 94.00 100.00 g
Aug-16 94.00Sep-16 94.00Oct-16 94.00Nov-16 94.00Dec-16 94.00Jan-17 94.00Feb-17 94.00
Mar-17 94.00
31 Day Subsequent Treatment (Tumour)
91.00
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
101.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 85.00 100.00 g
May-16 85.00 100.00 g
Jun-16 85.00 66.67 r
Jul-16 85.00 100.00 g
Aug-16 85.00Sep-16 85.00Oct-16 85.00Nov-16 85.00Dec-16 85.00Jan-17 85.00Feb-17 85.00
Mar-17 85.00
Cancer Plan 62 Days Standard (Tumour)
0.00
20.00
40.00
60.00
80.00
100.00
120.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 16
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 85.00 100.00 g
May-16 85.00 100.00 g
Jun-16 85.00 66.67 r
Jul-16 85.00 100.00 g
Aug-16 85.00Sep-16 85.00Oct-16 85.00Nov-16 85.00Dec-16 85.00Jan-17 85.00Feb-17 85.00
Mar-17 85.00
Cancer Plan 62 Days Standard (Tumour)
0.00
20.00
40.00
60.00
80.00
100.00
120.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Bone Tumour Services
Period Target Actual PerformanceApr-16 85.00 100.00 g
May-16 85.00 100.00 g
Jun-16 85.00 100.00 g
Jul-16 85.00 100.00 g
Aug-16 85.00Sep-16 85.00Oct-16 85.00Nov-16 85.00Dec-16 85.00Jan-17 85.00Feb-17 85.00
Mar-17 85.00
Cancer 62 Day Consultant Upgrade
75.00
80.00
85.00
90.00
95.00
100.00
105.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Services - English
Period Target Actual PerformanceApr-16 92.00 88.57 r
May-16 92.00 88.90 r
Jun-16 92.00 89.21 r
Jul-16 92.00 88.75 r
Aug-16 92.00Sep-16 92.00Oct-16 92.00Nov-16 92.00Dec-16 92.00Jan-17 92.00Feb-17 92.00
Mar-17 92.00
18 Weeks RTT Open Pathways
80.00
82.00
84.00
86.00
88.00
90.00
92.00
94.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Access to Services - English
Period Target Actual PerformanceApr-16 99.00 99.94 g
May-16 99.00 99.77 g
Jun-16 99.00 99.73 g
Jul-16 99.00 99.89 g
Aug-16 99.00Sep-16 99.00Oct-16 99.00Nov-16 99.00Dec-16 99.00Jan-17 99.00Feb-17 99.00
Mar-17 99.00
6 Week Wait for Diagnostics - English Patients
98.40
98.60
98.80
99.00
99.20
99.40
99.60
99.80
100.00
100.20
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 17
Balanced Scorecard - Trust
July 2016 - Month 4
Patient Experience
Access to Services - English
Period Target Actual PerformanceApr-16 99.00 99.94 g
May-16 99.00 99.77 g
Jun-16 99.00 99.73 g
Jul-16 99.00 99.89 g
Aug-16 99.00Sep-16 99.00Oct-16 99.00Nov-16 99.00Dec-16 99.00Jan-17 99.00Feb-17 99.00
Mar-17 99.00
6 Week Wait for Diagnostics - English Patients
98.40
98.60
98.80
99.00
99.20
99.40
99.60
99.80
100.00
100.20
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Patient Experience
Patients Waiting Over 52 Weeks
Period Target Actual Performance
Apr-16 0.00 4.00 r
May-16 0.00 4.00 r
Jun-16 0.00 9.00 r
Jul-16 0.00 10.00 r
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Patients Waiting Over 52 Weeks - English
0.00
5.00
10.00
15.00
20.00
25.00
30.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Patient Experience
Patients Waiting Over 52 Weeks
Period Target Actual Performance
Apr-16 0.00 35.00 r
May-16 0.00 24.00 r
Jun-16 0.00 20.00 r
Jul-16 0.00 10.00 r
Aug-16 0.00Sep-16 0.00Oct-16 0.00Nov-16 0.00Dec-16 0.00Jan-17 0.00Feb-17 0.00
Mar-17 0.00
Patients Waiting Over 52 Weeks - Welsh
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 18
Balanced Scorecard - Trust
July 2016 - Month 4
Resources
Period Target Actual PerformanceApr-16 3.00 3.47 aMay-16 3.00 3.39 aJun-16 3.00 3.53 aJul-16 3.00 3.30 a
Aug-16 3.00Sep-16 3.00Oct-16 3.00Nov-16 3.00Dec-16 3.00Jan-17 3.00Feb-17 3.00Mar-17 3.00
Sickness Absence
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Mean UCL LCL Actual
Resources
Period Target Actual PerformanceApr-16 91.00 91.31 g
May-16 91.00 90.89 a
Jun-16 91.00 90.39 a
Jul-16 91.00 91.05 g
Aug-16 91.00Sep-16 91.00Oct-16 92.00Nov-16 92.00Dec-16 92.00Jan-17 92.00Feb-17 92.00
Mar-17 92.00
Staff Stability Index
89.00
89.50
90.00
90.50
91.00
91.50
92.00
92.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Resources
Period Target Actual PerformanceApr-16 90.00 83.48 a
May-16 90.00 83.60 a
Jun-16 90.00 89.63 a
Jul-16 90.00 93.30 g
Aug-16 90.00Sep-16 90.00Oct-16 90.00Nov-16 90.00Dec-16 90.00Jan-17 90.00Feb-17 90.00
Mar-17 90.00
Staff Appraisal
78.00
80.00
82.00
84.00
86.00
88.00
90.00
92.00
94.00
96.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Resources
Period Target Actual PerformanceApr-16 90.00 94.20 g
May-16 90.00 95.70 g
Jun-16 90.00 95.50 g
Jul-16 90.00 97.80 g
Aug-16 90.00Sep-16 90.00Oct-16 90.00Nov-16 90.00Dec-16 90.00Jan-17 90.00Feb-17 90.00
Mar-17 90.00
Safe Staffing - % Shift Fill Rate
84.00
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
20.00
40.00
60.00
80.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 19
Balanced Scorecard - Trust
July 2016 - Month 4
Resources
Period Target Actual PerformanceApr-16 90.00 94.20 g
May-16 90.00 95.70 g
Jun-16 90.00 95.50 g
Jul-16 90.00 97.80 g
Aug-16 90.00Sep-16 90.00Oct-16 90.00Nov-16 90.00Dec-16 90.00Jan-17 90.00Feb-17 90.00
Mar-17 90.00
Safe Staffing - % Shift Fill Rate
84.00
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
102.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
20.00
40.00
60.00
80.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 20
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Demand for Services
Period Target Actual PerformanceApr-16 8500.00 10061.00 rMay-16 8500.00 10354.00 rJun-16 8500.00 10461.00 rJul-16 8500.00 10805.00 r
Aug-16 8500.00Sep-16 8500.00Oct-16 8500.00Nov-16 8500.00Dec-16 8500.00Jan-17 8500.00Feb-17 8500.00Mar-17 8500.00
Total Open Pathways
0.00
2000.00
4000.00
6000.00
8000.00
10000.00
12000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.0
2000.0
4000.0
6000.0
8000.0
10000.0
12000.0
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Demand for Services
Period Target Actual PerformanceApr-16 2908.00 2850.00 a
May-16 2908.00 2996.00 g
Jun-16 2908.00 3013.00 g
Jul-16 2908.00 No Data g
Aug-16 2618.00Sep-16 2908.00Oct-16 2908.00Nov-16 2908.00Dec-16 2327.00Jan-17 2908.00Feb-17 2908.00
Mar-17 2908.00
Referrals Received for Consultant Led Services
0.00
500.00
1000.00
1500.00
2000.00
2500.00
3000.00
3500.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
500.00
1000.00
1500.00
2000.00
2500.00
3000.00
3500.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Activity - Surgery
Period Target Actual PerformanceApr-16 1039.00 1064.00 g
May-16 969.00 988.00 g
Jun-16 1071.00 1057.00 a
Jul-16 1057.00 977.00 a
Aug-16 1005.00Sep-16 1096.00Oct-16 1085.00Nov-16 1093.00Dec-16 956.00Jan-17 1085.00Feb-17 1032.00
Mar-17 1129.00
Surgical Division Activity - Inpatient Contract
0.00
200.00
400.00
600.00
800.00
1000.00
1200.00
1400.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
200.00
400.00
600.00
800.00
1000.00
1200.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Activity - Surgery
Period Target Actual PerformanceApr-16 6493.00 6221.00 a
May-16 6055.00 6846.00 g
Jun-16 6689.00 7629.00 g
Jul-16 6604.00 6327.00 a
Aug-16 6279.00Sep-16 6848.00Oct-16 6776.00Nov-16 6828.00Dec-16 5971.00Jan-17 6776.00Feb-17 6449.00
Mar-17 7050.00
Surgical Division Activity - Outpatient Contract
0.00
1000.00
2000.00
3000.00
4000.00
5000.00
6000.00
7000.00
8000.00
9000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
1000.00
2000.00
3000.00
4000.00
5000.00
6000.00
7000.00
8000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 21
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Activity - Surgery
Period Target Actual PerformanceApr-16 6493.00 6221.00 a
May-16 6055.00 6846.00 g
Jun-16 6689.00 7629.00 g
Jul-16 6604.00 6327.00 a
Aug-16 6279.00Sep-16 6848.00Oct-16 6776.00Nov-16 6828.00Dec-16 5971.00Jan-17 6776.00Feb-17 6449.00
Mar-17 7050.00
Surgical Division Activity - Outpatient Contract
0.00
1000.00
2000.00
3000.00
4000.00
5000.00
6000.00
7000.00
8000.00
9000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
1000.00
2000.00
3000.00
4000.00
5000.00
6000.00
7000.00
8000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Activity - Medicine
Period Target Actual PerformanceApr-16 173.00 190.00 g
May-16 162.00 152.00 a
Jun-16 179.00 191.00 g
Jul-16 176.00 164.00 a
Aug-16 168.00Sep-16 183.00Oct-16 181.00Nov-16 182.00Dec-16 159.00Jan-17 181.00Feb-17 172.00
Mar-17 188.00
Medicine Division Activity - Inpatient Contract
0.00
50.00
100.00
150.00
200.00
250.00
300.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
50.00
100.00
150.00
200.00
250.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Activity - Medicine
Period Target Actual PerformanceApr-16 1577.00 1676.00 g
May-16 1471.00 1567.00 g
Jun-16 1625.00 1819.00 g
Jul-16 1604.00 1495.00 a
Aug-16 1525.00Sep-16 1663.00Oct-16 1646.00Nov-16 1659.00Dec-16 1451.00Jan-17 1646.00Feb-17 1566.00
Mar-17 1713.00
Medicine Division Activity - Outpatient Contract
0.00
200.00
400.00
600.00
800.00
1000.00
1200.00
1400.00
1600.00
1800.00
2000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
500.00
1000.00
1500.00
2000.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Daycase Performance
Period Target Actual PerformanceApr-16 83.00 81.84 a
May-16 83.00 83.28 g
Jun-16 84.00 81.94 a
Jul-16 84.00 85.96 g
Aug-16 85.00Sep-16 85.00Oct-16 86.00Nov-16 86.00Dec-16 87.00Jan-17 87.00Feb-17 88.00
Mar-17 88.00
BADS Activity
70.00
72.00
74.00
76.00
78.00
80.00
82.00
84.00
86.00
88.00
90.00
92.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 22
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Daycase Performance
Period Target Actual PerformanceApr-16 83.00 81.84 a
May-16 83.00 83.28 g
Jun-16 84.00 81.94 a
Jul-16 84.00 85.96 g
Aug-16 85.00Sep-16 85.00Oct-16 86.00Nov-16 86.00Dec-16 87.00Jan-17 87.00Feb-17 88.00
Mar-17 88.00
BADS Activity
70.00
72.00
74.00
76.00
78.00
80.00
82.00
84.00
86.00
88.00
90.00
92.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Daycase Performance
Period Target Actual PerformanceApr-16 50.00 51.46 g
May-16 50.00 46.51 a
Jun-16 50.00 47.63 a
Jul-16 51.00 46.62 a
Aug-16 51.00Sep-16 51.00Oct-16 52.00Nov-16 52.00Dec-16 52.00Jan-17 53.00Feb-17 53.00
Mar-17 53.00
Overall Daycase Rate
42.00
44.00
46.00
48.00
50.00
52.00
54.00
56.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
39.00
44.00
49.00
54.00
59.00
64.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Admission on Day of Surgery
Period Target Actual PerformanceApr-16 93.00 95.53 g
May-16 93.00 94.59 g
Jun-16 93.00 92.58 a
Jul-16 93.00 95.67 g
Aug-16 93.00Sep-16 93.00Oct-16 94.00Nov-16 94.00Dec-16 94.00Jan-17 95.00Feb-17 95.00
Mar-17 95.00
% of Elective NHS Inpatients Admitted on Day of Surgery
86.00
88.00
90.00
92.00
94.00
96.00
98.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Theatre Efficiency
Period Target Actual PerformanceApr-16 96.00 94.44 a
May-16 95.90 96.11 g
Jun-16 95.50 96.57 g
Jul-16 96.60 91.24 r
Aug-16 92.00Sep-16 96.70Oct-16 96.90Nov-16 97.90Dec-16 90.40Jan-17 96.80Feb-17 95.80
Mar-17 90.10
% Staffed Theatre Lists Utilised
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 23
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Theatre Efficiency
Period Target Actual PerformanceApr-16 96.00 94.44 a
May-16 95.90 96.11 g
Jun-16 95.50 96.57 g
Jul-16 96.60 91.24 r
Aug-16 92.00Sep-16 96.70Oct-16 96.90Nov-16 97.90Dec-16 90.40Jan-17 96.80Feb-17 95.80
Mar-17 90.10
% Staffed Theatre Lists Utilised
86.00
88.00
90.00
92.00
94.00
96.00
98.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
50.00
55.00
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Theatre Efficiency
Period Target Actual PerformanceApr-16 2.20 2.23 g
May-16 2.20 2.18 a
Jun-16 2.20 2.10 a
Jul-16 2.20 2.25 g
Aug-16 2.20Sep-16 2.20Oct-16 2.20Nov-16 2.20Dec-16 2.20Jan-17 2.25Feb-17 2.25
Mar-17 2.30
Theatre Cases Per Session
1.95
2.00
2.05
2.10
2.15
2.20
2.25
2.30
2.35
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Average Length of Stay
Period Target Actual Performance
Apr-16 4.00 3.65 g
May-16 3.90 3.76 g
Jun-16 3.90 3.85 g
Jul-16 3.80 3.85 a
Aug-16 3.80Sep-16 3.70Oct-16 3.60Nov-16 3.50Dec-16 3.50Jan-17 3.50Feb-17 3.50
Mar-17 3.50
Average Length of Stay - Elective Excluding Daycase
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
4.50
5.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Average Length of Stay
Period Target Actual PerformanceApr-16 55.00 73.00 g
May-16 55.00 63.73 g
Jun-16 55.00 70.69 g
Jul-16 60.00 64.02 g
Aug-16 60.00Sep-16 60.00Oct-16 65.00Nov-16 65.00Dec-16 65.00Jan-17 70.00Feb-17 70.00
Mar-17 70.00
% of Primary Hip and Knee Patients Discharged in 3 days or
less
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
42.00
47.00
52.00
57.00
62.00
67.00
72.00
77.00
82.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 24
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Average Length of Stay
Period Target Actual PerformanceApr-16 55.00 73.00 g
May-16 55.00 63.73 g
Jun-16 55.00 70.69 g
Jul-16 60.00 64.02 g
Aug-16 60.00Sep-16 60.00Oct-16 65.00Nov-16 65.00Dec-16 65.00Jan-17 70.00Feb-17 70.00
Mar-17 70.00
% of Primary Hip and Knee Patients Discharged in 3 days or
less
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
42.00
47.00
52.00
57.00
62.00
67.00
72.00
77.00
82.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Bed Utilisation
Period Target Actual PerformanceApr-16 78.00 63.51 rMay-16 80.00 69.42 rJun-16 80.00 75.34 gJul-16 81.00 71.98 r
Aug-16 82.00Sep-16 83.00Oct-16 84.00Nov-16 85.00Dec-16 86.00Jan-17 87.00Feb-17 87.00Mar-17 87.00
Bed Occupancy - Adult Orthopaedic Wards
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
%
Target Actual
Efficiency
Outpatient Productivity
Period Target Actual Performance
Apr-16 5.50 5.84 r
May-16 5.50 5.67 a
Jun-16 5.50 6.54 r
Jul-16 5.40 5.69 a
Aug-16 5.40Sep-16 5.40Oct-16 5.40Nov-16 5.30Dec-16 5.30Jan-17 5.20Feb-17 5.10
Mar-17 5.00
Outpatient DNA Rate
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
Efficiency
Period Target Actual Performance
Apr-16 2.90 2.34 g
May-16 2.90 2.23 g
Jun-16 2.80 2.37 g
Jul-16 2.80 2.22 g
Aug-16 2.70Sep-16 2.70Oct-16 2.60Nov-16 2.60Dec-16 2.60Jan-17 2.50Feb-17 2.50
Mar-17 2.50
New to Follow Up Ratio (Consultant Led Activity)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 25
Balanced Scorecard - Trust
July 2016 - Month 4
Efficiency
Period Target Actual Performance
Apr-16 2.90 2.34 g
May-16 2.90 2.23 g
Jun-16 2.80 2.37 g
Jul-16 2.80 2.22 g
Aug-16 2.70Sep-16 2.70Oct-16 2.60Nov-16 2.60Dec-16 2.60Jan-17 2.50Feb-17 2.50
Mar-17 2.50
New to Follow Up Ratio (Consultant Led Activity)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
Apr
-15
May
-15
Jun
-15
Jul-
15
Aug
-15
Sep
-15
Oct
-15
Nov
-15
Dec
-15
Jan-
16
Feb
-16
Mar
-16
Apr
-16
May
-16
Jun
-16
Jul-
16
Aug
-16
Sep
-16
Oct
-16
Nov
-16
Dec
-16
Jan-
17
Feb
-17
Mar
-17
Nu
mb
er
Target Actual
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 26
Finance Dashboard 31st July 2016Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Commentary
Income - Requires agreement of recovery plan to address YTD shortfall and further shortfalls are expected for August. Expenditure - Cost pressures in excess of reserves. CIP - Further mitigating schemes are being scoped and will in all likelihood be required to fully deliver plan.
Category Jun-16 Jul-16 Movement Drivers
Fixed Assets 66,416 66,804 389Capital investment above depreciation and impairment of Theatre 7
and HDU.
Non current receivables 653 642 (11)
Total Non Current Assets 67,069 67,447 378
Inventories (Stocks) 1,142 1,097 (45)
Receivables (Debtors) 5,966 5,911 (55) Reduction in contract over performance
Cash at Bank and in hand 4,895 4,601 (294)
Total Current Assets 12,003 11,608 (395)
Payables (Creditors) (9,983) (10,295) (312) PDC £0.1m and an increase in deferred income £0.2m.
Borrowings (1,030) (1,226) (196) Reclassification of loan repayment to current liability.
Current Provisions (526) (419) 107
Total Current Liabilities (< 1 year) (11,538) (11,940) (401)
Total Assets less Current Liabilities 67,533 67,115 (418)
Non Current Borrowings (9,045) (8,849) 196 Reclassification of loan repayment to current liability.
Non Current Provisions (143) (134) 10
Non Current Liabilities (> 1 year) (9,188) (8,983) 206
Total Assets Employed 58,344 58,133 (212)
Public Dividend Capital (33,260) (33,260) 0
Revenue Position (1,007) (795) 212 Small in month surplus £41k offset by impairment (£253k)
Retained Earnings (6,766) (7,019) (253) Impairment of Theatre 7 & HDU
Revaluation Reserve (17,312) (17,059) 253 Impairment of Theatre 7 & HDU
Total Taxpayers Equity (58,344) (58,133) 212
Statement of Financial Position £'000s
Jul-16 YTD
Debtor Days 26 24
Creditor Days 42 41
Plan Actual Variance
Clinical Income from activity 88,800 29,114 28,975 (139) (263)
Private Patient income 4,870 1,580 1,149 (431) (137)
Other income 6,130 2,059 2,135 76 (37)
Pay (55,452) (18,274) (18,068) 206 107
Non-pay (38,585) (12,668) (12,600) 68 160
EBITDA 5,764 1,811 1,590 (220) (171)
Finance Costs (4,348) (1,342) (1,243) 99 24
Capital Donations 1,000 500 700 200 0
Operational Surplus 2,416 969 1,048 79 (146)
Remove Capital Donations (1,000) (500) (700) (200)0
Add Back Donated Dep'n 571 174 160 (14) (4)
Remove STF Funding (500) (167) (167) 0 0
Control Total 1,487 476 341 (135) (150)
STF Earnt 500 167 167 0 0
Planned Surplus 1,987 643 507 (135) (150)
EBITDA margin 5.8% 5.5% 4.9% -0.6%
Income and Expenditure £'000s
Movement In
Variance From
Prior Month
CategoryAnnual
Plan
Year To Date Position
Debt Service Cover 4 I&E Margin 4
Liquidity (days) 3 Variance in I&E Margin 4
Overall FSRR 4
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17
C
a
s
h
£
M
Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17
Monitor Plan £M 5.4 4.7 4.9 4.8 4.7 4.6 4.9 5.1 5.2 5.4 4.8 4.2
Actual £M 4.8 4.7 4.9 4.6
Forecast £M 4.8 4.7 4.9 4.8 4.4 3.6 4.4 4.8 5.1 5.2 4.8 4.2
Cash Flow
Risks
Income Risk High
Expenditure Risk Low
CIP Risk Medium
(£200)
£0
£200
£400
£600
£800
£1,000
£1,200
£1,400
£1,600
Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17
S
u
r
p
l
i
u
s
/
(
D
e
f
i
c
i
t)
Period
Monthly Surplus/Deficit
Plan
Actual
(£600)
(£500)
(£400)
(£300)
(£200)
(£100)
£0
Clinical Income fromactivity
Private Patient income Other income Pay Non-pay
V
a
r
i
a
n
c
e
Cumulative Variances £'000s
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 27
RAG of Total Schemes Being Tracked
2,387 68.2% g
857 24.5% a
256 7.3% r
3,500 100.0%
Ca
pit
al
Co
mm
issio
ne
r P
erf
orm
an
ce
In Month CIP Achievement £000's Year To Date CIP Achievement £000's
CIP
by T
he
me
Year To Date Commissioner Income against Plan £m
CIP
by D
ivis
ion
Year to date capital programme £000's
Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation TrustFinance Dashboard 31st July 2016
Cost Improvement Programme
In Month CIP Achievement £000's Year To Date CIP Achievement £000's Trust YTD Achievement Against YTD Plan £000's
(10) 0 10 20 30 40 50 60 70 80
Bring Forward FYE
Capacity Alignment
Productivity
Procurement
Transformation
Workforce Redesign
Income
Miscellaneous
Jul Plan Jul Actual
0
100
200
300
400
500
600
700
800
Total
YTD Plan YTD Actual
0 50 100 150 200 250
Bring Forward FYE
Capacity Alignment
Productivity
Procurement
Transformation
Workforce Redesign
Income
Miscellaneous
YTD Plan YTD Actual
0 20 40 60 80 100
Surgery
Medicine
Diagnostics
Estates & Facilities
Corporate
Theatres
Jun Plan Jul Actual
0 50 100 150 200 250 300 350
Surgery
Medicine
Diagnostics
Estates & Facilities
Corporate
Theatres
YTD Plan YTD Actual
- 2.00 4.00 6.00 8.00 10.00 12.00
Shropshire
BCU
Specialist
Other English Contracted
Powys
Telford
Other
Uncontracted
YTD actual YTD plan
ProjectAnnual
Plan
Year to
date Plan
Year to
date
Completed
Year to
date
Variance
In Month
Actual
Forecast
Outturn
Outturn
Variance
Backlog Maintenance 430 108 103 5 79 800 -370
Medical equipment 400 0 332 -332 137 400 0
Plated Meal Trollies 200 200 195 5 0 200 0
IT 300 40 60 -20 29 300 0
Project Management 170 80 59 21 13 170 0
Contingency 300 33 0 33 0 224 76
Theatre and Tumour Development 2,440 2,099 2,162 -63 417 2,516 -76
Outpatients Department Upgrade 300 0 9 -9 0 300 0
Increased Theatre Capacity 500 0 0 0 0 130 370
NHS Capital Expenditure 5,040 2,560 2,920 -360 675 5,040 0
Theatre and Tumour Equipment 0 0 150 -150 150 150 -150
Donated Capital Funding 0 0 150 -150 150 150 -150
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 28
Month 4
Achieved / Not Met
Referral to treatment time, 18 weeks in aggregate, incomplete pathways 92% 1.0 Yes Not met
Cancer 62 Day Waits for first treatment (from urgent GP referral) 85% 1.0 No Achieved
Cancer 62 Day Waits for first treatment (from NHS Cancer Screening Service
referral)90% 1.0 No Not relevant
Cancer 31 day wait for second or subsequent treatment - surgery 94% 1.0 No Not relevant
Cancer 31 day wait for second or subsequent treatment - drug treatments 98% 1.0 No Not relevant
Cancer 31 day wait for second or subsequent treatment - radiotherapy 94% 1.0 No Not relevant
Cancer 31 day wait from diagnosis to first treatment 96% 0.5 No Achieved
Cancer 2 week (all cancers) 93% 0.5 No Achieved
Clostridium Difficile -meeting the C.Diff objective 2 1.0 No Achieved
Risk of, or actual, failure to deliver Commissioner Requested Services N/A No No
CQC enforcement action within last 12 months (as at 31 Mar 2015) N/A No No
CQC enforcement action (including notices) currently in effect (as at 31 Mar
2015)N/A No No
CQC enforcement action (including notices) currently in effect N/A No No
Moderate CQC concerns or impacts regarding the safety of healthcare provision N/A No No
Major CQC concerns or impacts regarding the safety of healthcare provision N/A No No
Unable to maintain, or certify, a minimum published CNST level of 1.0 or have in
place appropriate alternative arrangementsN/A No No
Score of 7 or less in standard 1 assessment at last NHSLA CNST inspection
(maternity or all services)N/A No No
Trust unable to declare ongoing compliance with minimum standards of CQC
registrationN/A No No
0
RED
Appendix 1
Indicative Risk Rating
Declaration of risks against healthcare targets and indicators for 2016/17
Target or Indicator (per Risk Assessment Framework)
Threshold
or target
YTD
Scoring
Risk
declared at
Annual Plan
Overall Score
Report by
Exception
U:\Trust Board & Committees\Public Trust Board\2016-17\August 2016\Month 04 Integrated Performance Report 29
